The day forms part of a series of meetings of the MHRA’s HF Task Group, designed to clarify the expectations of regulatory bodies and to provide human factors guidance to manufacturers of all device classes (including drug/device products) who intend to market their device in the UK.
John Wilkinson, Director of the Devices Division at the MHRA will chair the meeting.
MDU are delighted to be one of the MHRA stakeholder organisations and are providing advice on the upcoming guidelines. More information about the MHRA’s HF Task Group can be found on the MDU blog at http://bit.ly/1PiAZrj